* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
To an oven dried tube is added palladium acetate (about 10 mg) and 2,2’-bis-dicyclohexylphosphanylbiphenyl(about 30 mg), 8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine (about 75 mg), 1-(3-bromo-phenyl)-4-methylpiperazine (about 80 mg), a suitable base, such as cesium carbonate (about 270 mg) anda suitable solvent, such as 1,4-dioxane (about 5 mL). The tube is evacuated and backflushed with nitrogen threetimes. The tube is sealed and heated at about 80°C for about 72 hours. The mixture is cooled to room temperatureand the product isolated in a suitable manner. For example, the cooled mixture may be diluted with dichloromethane(about 10 mL), filtered through a plug of diatomaceous earth, rinsed with dichloromethane and evaporated. Thematerial may then be purified, e.g., via chromatography, e.g., utilizing an ISCO automated purification apparatus(e.g., amine modified silica gel column 5percent→100percent ethyl acetate in hexanes). [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine (i.e., COMPOUND A) is isolated as a yellowsolid (about 0.07 g). MP = 232-234 °C. 1H NMR (400 MHz, CDCl3, δ, ppm): 8.49 (d, J=7.2 Hz, 1H), 8.25 (d, J=7.5Hz, 2H), 8.08 (d, J=7.9 Hz, 2H), 7.65 (d, J=7.7 Hz, 1H), 7.38 (s, 1H), 7.27-7.20 (m, 1H), 7.04-6.95 (m, 2H), 6.84 (s,1H), 6.60 (d, J=8.0 Hz, 1H), 3.30-3.25 (m, 4H), 3.10 (s, 3H), 2.63-2.58 (m, 4H), 2.38 (s, 3H). MS = 463 (MH)+
Reference:
[1] Journal of Medicinal Chemistry, 2012, vol. 55, # 11, p. 5243 - 5254
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Patent: EP2648728, 2016, B1, . Location in patent: Paragraph 0047
2
[ 13534-99-1 ]
[ 1257704-57-6 ]
Reference:
[1] Journal of Medicinal Chemistry, 2012, vol. 55, # 11, p. 5243 - 5254
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[4] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[5] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[6] Patent: EP2648728, 2016, B1,
3
[ 1124382-72-4 ]
[ 1257704-57-6 ]
Reference:
[1] Journal of Medicinal Chemistry, 2012, vol. 55, # 11, p. 5243 - 5254
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[4] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[5] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
4
[ 1124383-00-1 ]
[ 1257704-57-6 ]
Reference:
[1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[4] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[5] Patent: EP2648728, 2016, B1,
5
[ 149104-88-1 ]
[ 1257704-57-6 ]
Reference:
[1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
6
[ 31197-30-5 ]
[ 1257704-57-6 ]
Reference:
[1] Patent: EP2648728, 2016, B1,
7
[ 1257704-13-4 ]
[ 1257704-57-6 ]
Reference:
[1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
8
[ 108-36-1 ]
[ 1257704-57-6 ]
Reference:
[1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
9
[ 109-01-3 ]
[ 1257704-57-6 ]
Reference:
[1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
10
[ 1257706-00-5 ]
[ 148546-99-0 ]
[ 1257704-57-6 ]
Reference:
[1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091